FDA - HealthQuill

Harm Reduction Therapeutics’s RiVive has become the second opioid overdose reversal drug the FDA allows without a prescription in the US.

USFDA gives nod for second opioid overdose reversal drug ReVive

HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid.

by HealthQuill
July 30, 2023
0 Comments

Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement

Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,.

by HealthQuill
July 29, 2023
0 Comments

Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved by the FDA for people between 18 and 65 years.

Drugs Health Pharma

US-based Emergent’s anthrax vaccine gets FDA clearance

HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.

by HealthQuill
July 24, 2023
0 Comments

US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious viral skin disease, the company announced.

Drugs Health Pharma

USFDA green lights Verrica’s drug to treat contagious viral skin disease

HQ Team July 24, 2023: US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious.

by HealthQuill
July 24, 2023
0 Comments

Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.

Drugs Health Pharma

Eli Lilly: Alzheimer’s test drug slows cognitive decline in early stages

HQ Team July 18, 2023: Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of.

by HealthQuill
July 18, 2023
0 Comments

The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the US, according to a statement from the regulator.

Drugs Health Pharma

USFDA allows first oral contraceptive without a prescription

HQ Team July 14, 2023: The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the.

by HealthQuill
July 14, 2023
0 Comments

Research uncovers significant discrepancies in ingredient labels and presence of banned compounds

Drugs Health Pharma

US combats new high of animal sedative Tranq, fentanyl, heroin mix

HQ Team July 12, 2023: Xylazine hydrochloride, a sedative used in animals to provide relief from pain, is increasingly being found in the.

by HealthQuill
July 12, 2023
0 Comments

The FDA has told e-cigarette maker Fontem US, LLC, not to market or distribute its product myblu menthol in the US as it did not provide any “added benefits.”

Drugs Health Pharma

FDA bans Fontem US from selling e-cigarette myblu menthol

HQ Team July 11, 2023: The FDA has told e-cigarette maker Fontem US, LLC, not to market or distribute its product myblu menthol.

by HealthQuill
July 11, 2023
0 Comments

The USFDA has granted a standard approval for Eisai and Biogen's Alzheimer injection, Leqembi —the first treatment to secure the traditional approval, paving the way for wider insurance coverage of the drug.

Drugs Health Pharma

USFDA grants green light to Eisai, Biogen’s Alzheimer’s drug Leqembi

HQ Team July 7, 2023: The USFDA has granted a standard approval for Eisai and Biogen’s Alzheimer injection, Leqembi —the first treatment to secure the.